NUS develops new experimental treatment for rare form of blood cancer
A new experimental cell therapy developed in Singapore could potentially treat a rare form of blood cancer. A clinical trial of this treatment on patients with T-cell acute lymphoblastic leukaemia has shown a remission rate of 94 per cent. It was developed in-house by researchers and clinicians from the Yong Loo Lin School of Medicine at the National University of Singapore.
A new experimental cell therapy developed in Singapore could potentially treat a rare form of blood cancer. A clinical trial of this treatment on patients with T-cell acute lymphoblastic leukaemia has shown a remission rate of 94 per cent. It was developed in-house by researchers and clinicians from the Yong Loo Lin School of Medicine at the National University of Singapore.
Popular Shows
